Literature DB >> 23245472

MicroRNA-122-dependent and -independent replication of Hepatitis C Virus in Hep3B human hepatoma cells.

Patricia A Thibault1, Adam Huys, Pearl Dhillon, Joyce A Wilson.   

Abstract

The study of Hepatitis C Virus (HCV) has benefitted from the use of the Huh7 cell culture system, but until recently there were no other widely used alternatives to this cell line. Here we render another human hepatoma cell line, Hep3B, permissive to the complete virus life cycle by supplementation with the liver-specific microRNA miR-122, known to aid HCV RNA accumulation. When supplemented, Hep3B cells produce J6/JFH-1 virus titres indistinguishable from those produced by Huh7.5 cells. Interestingly, we were able to detect and characterize miR-122-independent replication of di-cistronic replicons in Hep3B cells. Further, we show that Argonaute-2 (Ago2) is required for miR-122-dependent replication, but dispensable for miR-122-independent replication, confirming Ago2's role in mediating the activity of miR-122. Thus Hep3B cells are a model system for the study of HCV, and miR-122 independent replication is a model to identify proteins involved in the function of miR-122.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23245472     DOI: 10.1016/j.virol.2012.11.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  High serum microRNA-122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients.

Authors:  Yongqing Xu; Xianmin Bu; Chaoliu Dai; Chao Shang
Journal:  Tumour Biol       Date:  2015-02-01

2.  Regulation of Hepatitis C Virus Genome Replication by Xrn1 and MicroRNA-122 Binding to Individual Sites in the 5' Untranslated Region.

Authors:  Patricia A Thibault; Adam Huys; Yalena Amador-Cañizares; Julie E Gailius; Dayna E Pinel; Joyce A Wilson
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

Review 3.  cis-Acting RNA elements in the hepatitis C virus RNA genome.

Authors:  Selena M Sagan; Jasmin Chahal; Peter Sarnow
Journal:  Virus Res       Date:  2015-01-07       Impact factor: 3.303

4.  Cellular DEAD-box RNA helicase DDX6 modulates interaction of miR-122 with the 5' untranslated region of hepatitis C virus RNA.

Authors:  Jason M Biegel; Eric Henderson; Erica M Cox; Gaston Bonenfant; Rachel Netzband; Samantha Kahn; Rachel Eager; Cara T Pager
Journal:  Virology       Date:  2017-04-26       Impact factor: 3.616

5.  MicroRNA 122 Affects both the Initiation and the Maintenance of Hepatitis C Virus Infections.

Authors:  Mamata Panigrahi; Patricia A Thibault; Joyce A Wilson
Journal:  J Virol       Date:  2021-12-15       Impact factor: 6.549

6.  Manipulation of cellular processing bodies and their constituents by viruses.

Authors:  Asit K Pattnaik; Phat X Dinh
Journal:  DNA Cell Biol       Date:  2013-04-25       Impact factor: 3.311

7.  Modulation of GB virus B RNA abundance by microRNA-122: dependence on and escape from microRNA-122 restriction.

Authors:  Selena M Sagan; Peter Sarnow; Joyce A Wilson
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

Review 8.  The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA.

Authors:  You Li; Daisuke Yamane; Takahiro Masaki; Stanley M Lemon
Journal:  Nat Rev Microbiol       Date:  2015-08-10       Impact factor: 60.633

9.  Chlamydia muridarum infection associated host MicroRNAs in the murine genital tract and contribution to generation of host immune response.

Authors:  Rishein Gupta; Tanvi Arkatkar; Jieh-Juen Yu; Shradha Wali; William E Haskins; James P Chambers; Ashlesh K Murthy; Sazaly Abu Bakar; M Neal Guentzel; Bernard P Arulanandam
Journal:  Am J Reprod Immunol       Date:  2014-06-28       Impact factor: 3.886

10.  Modulation of hepatitis C virus RNA accumulation and translation by DDX6 and miR-122 are mediated by separate mechanisms.

Authors:  Adam Huys; Patricia A Thibault; Joyce A Wilson
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.